| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 1.51e-04 | 749 | 32 | 7 | GO:0005509 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 6.72e-04 | 24 | 32 | 2 | GO:0004745 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 7.37e-04 | 111 | 32 | 3 | GO:0003727 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 7.89e-04 | 26 | 32 | 2 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.05e-03 | 30 | 32 | 2 | GO:0018455 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.76e-08 | 53 | 32 | 5 | GO:0016339 | |
| GeneOntologyBiologicalProcess | synapse assembly | 6.90e-06 | 308 | 32 | 6 | GO:0007416 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 9.58e-06 | 187 | 32 | 5 | GO:0007156 | |
| GeneOntologyBiologicalProcess | neuroinflammatory response | 1.75e-05 | 101 | 32 | 4 | GO:0150076 | |
| GeneOntologyBiologicalProcess | regulation of neuroinflammatory response | 4.92e-05 | 46 | 32 | 3 | GO:0150077 | |
| GeneOntologyBiologicalProcess | synapse organization | 7.04e-05 | 685 | 32 | 7 | GO:0050808 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.12e-04 | 313 | 32 | 5 | GO:0098742 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 2.11e-04 | 569 | 32 | 6 | GO:0034329 | |
| GeneOntologyBiologicalProcess | kidney development | 2.51e-04 | 372 | 32 | 5 | GO:0001822 | |
| GeneOntologyBiologicalProcess | renal system development | 2.97e-04 | 386 | 32 | 5 | GO:0072001 | |
| Domain | Cadherin_C_2 | 7.31e-09 | 42 | 31 | 5 | PF16492 | |
| Domain | Cadherin_C | 7.31e-09 | 42 | 31 | 5 | IPR032455 | |
| Domain | Cadherin_N | 6.92e-08 | 65 | 31 | 5 | IPR013164 | |
| Domain | Cadherin_2 | 6.92e-08 | 65 | 31 | 5 | PF08266 | |
| Domain | Cadherin_CS | 9.29e-07 | 109 | 31 | 5 | IPR020894 | |
| Domain | Cadherin | 1.11e-06 | 113 | 31 | 5 | PF00028 | |
| Domain | CADHERIN_1 | 1.11e-06 | 113 | 31 | 5 | PS00232 | |
| Domain | CADHERIN_2 | 1.16e-06 | 114 | 31 | 5 | PS50268 | |
| Domain | - | 1.16e-06 | 114 | 31 | 5 | 2.60.40.60 | |
| Domain | CA | 1.21e-06 | 115 | 31 | 5 | SM00112 | |
| Domain | Cadherin-like | 1.27e-06 | 116 | 31 | 5 | IPR015919 | |
| Domain | Cadherin | 1.38e-06 | 118 | 31 | 5 | IPR002126 | |
| Domain | Sc_DH/Rdtase_CS | 1.53e-03 | 35 | 31 | 2 | IPR020904 | |
| Domain | ADH_SHORT | 3.49e-03 | 53 | 31 | 2 | PS00061 | |
| Domain | adh_short | 3.75e-03 | 55 | 31 | 2 | PF00106 | |
| Domain | SDR_fam | 3.88e-03 | 56 | 31 | 2 | IPR002347 | |
| Domain | WD40 | 8.90e-03 | 259 | 31 | 3 | PF00400 | |
| Domain | WD40 | 9.76e-03 | 268 | 31 | 3 | SM00320 | |
| Domain | WD40_repeat | 1.02e-02 | 272 | 31 | 3 | IPR001680 | |
| Domain | WD_REPEATS_1 | 1.08e-02 | 278 | 31 | 3 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.09e-02 | 279 | 31 | 3 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.09e-02 | 279 | 31 | 3 | PS50294 | |
| Domain | WD40_repeat_dom | 1.29e-02 | 297 | 31 | 3 | IPR017986 | |
| Domain | - | 1.75e-02 | 333 | 31 | 3 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.77e-02 | 335 | 31 | 3 | IPR015943 | |
| Pubmed | 6.08e-13 | 13 | 32 | 5 | 12231349 | ||
| Pubmed | 7.29e-12 | 20 | 32 | 5 | 11322959 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.92e-09 | 57 | 32 | 5 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 2.10e-09 | 58 | 32 | 5 | 30377227 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 4.75e-09 | 68 | 32 | 5 | 11230163 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 6.36e-09 | 72 | 32 | 5 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 7.32e-09 | 74 | 32 | 5 | 10817752 | |
| Pubmed | 8.96e-09 | 77 | 32 | 5 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.09e-08 | 80 | 32 | 5 | 10716726 | |
| Pubmed | 4.77e-07 | 17 | 32 | 3 | 18279309 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 28105703 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 29417309 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 23525523 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 28849217 | ||
| Pubmed | Identification of novel cadherins expressed in human melanoma cells. | 1.72e-05 | 7 | 32 | 2 | 9182820 | |
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 2.22e-05 | 59 | 32 | 3 | 23754746 | |
| Pubmed | Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L. | 2.94e-05 | 9 | 32 | 2 | 21041412 | |
| Pubmed | Hedgehog signaling maintains hair follicle stem cell phenotype in young and aged human skin. | 5.38e-05 | 12 | 32 | 2 | 20050020 | |
| Pubmed | 7.41e-05 | 14 | 32 | 2 | 16935278 | ||
| Pubmed | A unique role of cohesin-SA1 in gene regulation and development. | 9.76e-05 | 16 | 32 | 2 | 22415368 | |
| Pubmed | 1.39e-04 | 19 | 32 | 2 | 23920377 | ||
| Pubmed | Gamma protocadherins are required for survival of spinal interneurons. | 2.63e-04 | 26 | 32 | 2 | 12467588 | |
| Pubmed | Roles and functions of HIV-1 Tat protein in the CNS: an overview. | 2.84e-04 | 27 | 32 | 2 | 24359561 | |
| Pubmed | Abnormal neocortex arealization and Sotos-like syndrome-associated behavior in Setd2 mutant mice. | 3.05e-04 | 28 | 32 | 2 | 33523829 | |
| Pubmed | Mesenchyme-derived vertebrate lonesome kinase controls lung organogenesis by altering the matrisome. | 4.00e-04 | 32 | 32 | 2 | 36920550 | |
| Pubmed | Analysis of mouse embryonic patterning and morphogenesis by forward genetics. | 4.25e-04 | 33 | 32 | 2 | 15755804 | |
| Pubmed | Sterile Inflammation Enhances ECM Degradation in Integrin β1 KO Embryonic Skin. | 5.65e-04 | 38 | 32 | 2 | 27653694 | |
| Interaction | PCDHB9 interactions | 7.32e-06 | 3 | 32 | 2 | int:PCDHB9 | |
| Interaction | PCDHB4 interactions | 7.32e-06 | 3 | 32 | 2 | int:PCDHB4 | |
| Interaction | PCDHB10 interactions | 5.10e-05 | 7 | 32 | 2 | int:PCDHB10 | |
| Interaction | PCDHB3 interactions | 7.09e-05 | 141 | 32 | 4 | int:PCDHB3 | |
| Cytoband | 5q31 | 1.72e-08 | 115 | 32 | 5 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 1.94e-06 | 298 | 32 | 5 | chr5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 4.13e-03 | 137 | 32 | 2 | chr1p22 | |
| GeneFamily | Clustered protocadherins | 2.94e-08 | 64 | 26 | 5 | 20 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 5.31e-03 | 76 | 26 | 2 | 743 | |
| GeneFamily | WD repeat domain containing | 6.11e-03 | 262 | 26 | 3 | 362 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN | 4.19e-06 | 200 | 32 | 5 | M5600 | |
| Disease | pleural tuberculosis (is_marker_for) | 4.18e-05 | 10 | 29 | 2 | DOID:106 (is_marker_for) | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 8.43e-05 | 14 | 29 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | ocular hypertension (biomarker_via_orthology) | 1.26e-04 | 17 | 29 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | squamous cell carcinoma (is_marker_for) | 1.58e-04 | 19 | 29 | 2 | DOID:1749 (is_marker_for) | |
| Disease | glaucoma (is_marker_for) | 1.75e-04 | 20 | 29 | 2 | DOID:1686 (is_marker_for) | |
| Disease | stomach cancer (is_marker_for) | 3.64e-04 | 142 | 29 | 3 | DOID:10534 (is_marker_for) | |
| Disease | colorectal cancer (is_marker_for) | 4.88e-04 | 157 | 29 | 3 | DOID:9256 (is_marker_for) | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 6.08e-04 | 37 | 29 | 2 | DOID:0050865 (is_marker_for) | |
| Disease | Drug-Induced Liver Disease | 6.27e-04 | 404 | 29 | 4 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 6.27e-04 | 404 | 29 | 4 | C3658290 | |
| Disease | Hepatitis, Toxic | 6.27e-04 | 404 | 29 | 4 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 6.27e-04 | 404 | 29 | 4 | C4279912 | |
| Disease | Chemical and Drug Induced Liver Injury | 6.27e-04 | 404 | 29 | 4 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 6.27e-04 | 404 | 29 | 4 | C1262760 | |
| Disease | very long-chain saturated fatty acid measurement | 8.60e-04 | 44 | 29 | 2 | EFO_0006796 | |
| Disease | Liver Cirrhosis, Experimental | 8.63e-04 | 774 | 29 | 5 | C0023893 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FVFTTDELKYSCGLG | 421 | Q6ZU67 | |
| YGEEVTYKCFEGFGI | 951 | P08603 | |
| CTKFFVGTEEGEVIY | 631 | Q8IWG1 | |
| VGTLYECFGSDGKLV | 116 | O94817 | |
| FTFLGKEYSTCTSEG | 351 | P14780 | |
| SGIASCVFTKYGQGF | 896 | Q6P1M3 | |
| ITEGCVSKYSGVFSF | 1616 | Q96RT7 | |
| FSGVYGTCIGATNKF | 256 | O43934 | |
| FGFGKISGTACLTVY | 126 | P41217 | |
| KGFGVVCFSSFEEAT | 341 | Q96DU9 | |
| EVCLTGDSGTGEFKF | 751 | Q9Y5E5 | |
| YEVCLTGGSETSEFK | 751 | Q9NRJ7 | |
| YEVCLTGGSGTNEFK | 751 | Q9Y5E9 | |
| VECFAFGISGVQKYT | 91 | O95760 | |
| EGICSGKYFTESGLV | 1761 | Q96N67 | |
| AVIGGGYCVSKFGVE | 166 | Q8NEX9 | |
| GVVSGGVVCFFPSYE | 716 | Q92771 | |
| TYCSVGVFFPGTGKV | 41 | P48723 | |
| IFEGGKATCFAYGQT | 336 | Q99661 | |
| YEVCLTGGSGTNEFK | 751 | Q9Y5E6 | |
| YEVCLTGGSETGEFK | 751 | Q9Y5E1 | |
| YAVKVIDVTGGGSFS | 46 | Q16816 | |
| TCRGGTTKVFLVGDY | 86 | P08247 | |
| VCFTKGYGSYIEGTG | 291 | O14717 | |
| SGGYVATIGTKFCAL | 66 | Q15493 | |
| GVEDYCASKFGVVGF | 206 | Q8IZV5 | |
| GGTSICSGIKYAFQV | 381 | Q14CN2 | |
| FTEVEGTCTGKYGFV | 31 | P62487 | |
| GTCTGKYGFVIAVTT | 36 | P62487 | |
| GEDFVLYCFSTVTGK | 461 | Q2TAY7 | |
| VDGDSVSGICFVGYK | 381 | Q99835 | |
| VECGKGFSFSSDYII | 591 | P17027 | |
| AEVIYCSFGGTSKGL | 61 | Q8NFA0 |